# OnCo record paper-cassiopeia-lancet-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cassiopeia-lancet-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cassiopeia-lancet-2019" ;
  schema:name "CASSIOPEIA: daratumumab added to bortezomib, thalidomide and dexamethasone before and after transplant in newly diagnosed myeloma"@en ;
  schema:description "Adding the antibody daratumumab to a standard three-drug induction and consolidation around autologous transplant deepened responses and delayed progression in newly diagnosed myeloma, establishing four-drug induction."@en ;
  schema:url <https://onco.cc/key-papers/paper-cassiopeia-lancet-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(19)31240-1>, <https://pubmed.ncbi.nlm.nih.gov/31171419/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(19)31240-1> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Moreau P, Attal M, Hulin C, et al." ;
  onco:cancers <https://onco.cc/cancers/myeloma-transplant-eligible/> ;
  onco:drugs <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/daratumumab/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/thalidomide/> ;
  onco:trials <https://onco.cc/trials/cassiopeia/> ;
  onco:journals <https://onco.cc/journals/lancet/> .